News & Events

News

News
Perimeter reports financial results for its fourth quarter and full year ended December 31, 2024 along with a corporate update.
News
Perimeter announces the submission of a Premarket Approval application to the U.S. Food and Drug Administration for the Company's next-generation Perimeter B-Series OCT system, which combines proprietary artificial intelligence technology with optical coherence tomography, for use during breast-conserving surgeries in the United States.
News
Perimeter announces that Covenant Health Fort Sanders Regional is the first hospital in Tennessee to use the company's S-Series OCT technology to visualize tissue margins in the operating room.
News
Perimeter announces that detailed results from the pivotal trial evaluating the use of its next-generation B-Series OCT with ImgAssist AI 2.0 during breast-conserving surgeries will be presented during the scientific session of the 26th Annual Meeting of the American Society of Breast Surgeons taking place in Las Vegas, NV, April 30 - May 4, 2025.
News
Perimeter announces that its common shares will begin trading on the OTCQX® Best Market under the symbol "PYNKF", effective with the open of business on February 27, 2025.
News
Perimeter announces that CHRISTUS St. Vincent is the first hospital in New Mexico to use the company's S-Series OCT technology to visualize tissue margins in the operating room.

View All

Events

American Society of Breast Surgeons Annual Meeting 2025

We’re attending the 2025 ASBrS Annual Meeting, and have some exciting opportunities to connect! Visit Booth 422 to experience the S-Series OCT, giving surgeons microscopic clarity on margins to act in the moment and close with confidence. Meet our Med Affairs team and get a demo of our investigational AI-enhanced OCT technology.

Learn More

Continue Exploring

Education

Benefits to Surgeons

Clinical Trials

Ready to learn more about Perimeter?

Get Started